Mr Fadıllıoğlu, after a previous position at Abbott, you were recently appointed head of GSK Turkey. How different is GSK as an organization? What new therapeutic…
In Conversation
Mr Acar, could you present to our readers the Institution’s historical development and its role today in the Turkish pharmaceutical and healthcare sector? Before Social Security…
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a…
You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to…
Mr Yusuf, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. Having been instrumental in…
With forty years of experience behind your belt, you founded JOSWE in 2000. What were the opportunities in the market that you saw to establish the…
IEIS is an association with dual responsibilities. Promotion of generic usage in turkey and ensuring the sustained development of a local manufacturing industry. Before we look…
The Association was founded in 1984 and has played an important role throughout the decades improving the standards of the country’s private hospitals. How important is…
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a…
Mr. Jaouni, what do you understand as the vision of the Ali Bin Ali family in betting on the medical field and establishing Ali Bin Ali…
You have been Levant manager for 5 years now and the one that set up AstraZeneca in Jordan. How challenging has it been to establish the…
